INMD Key Statistics, Chart & Performance
The current stock price of INMD is 14.03 USD. In the past month the price decreased by -11.69%. In the past year, price decreased by -29.24%.
INMD Latest News, Press Relases and Analysis
INMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.65 | 222.80B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.94 | 206.60B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.25 | 149.73B | ||
| SYK | STRYKER CORP | 28.51 | 143.54B | ||
| IDXX | IDEXX LABORATORIES INC | 60.4 | 60.93B | ||
| BDX | BECTON DICKINSON AND CO | 13.47 | 55.68B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.68 | 50.22B | ||
| RMD | RESMED INC | 25.41 | 36.72B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.65 | 36.91B | ||
| DXCM | DEXCOM INC | 33.26 | 24.26B | ||
| PODD | INSULET CORP | 71.86 | 23.10B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.94 | 19.13B |
Related stock screener links
About INMD
Company Profile
InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The firm have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Company Info
INMODE LTD
Tavor Building, Sha'ar Yokneam, Pob 533
Yokneam 2069200 IL
CEO: Moshe Mizrahy
Employees: 599
Phone: 97249097470
INMODE LTD / INMD FAQ
Can you describe the business of INMODE LTD?
InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The firm have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
What is the current price of INMD stock?
The current stock price of INMD is 14.03 USD. The price increased by 1.52% in the last trading session.
Does INMODE LTD pay dividends?
INMD does not pay a dividend.
What is the ChartMill technical and fundamental rating of INMD stock?
INMD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
How is the market expecting INMD stock to perform?
13 analysts have analysed INMD and the average price target is 17.14 USD. This implies a price increase of 22.14% is expected in the next year compared to the current price of 14.03.
Can you provide the sector and industry classification for INMODE LTD?
INMODE LTD (INMD) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Can you provide the upcoming earnings date for INMODE LTD?
INMODE LTD (INMD) will report earnings on 2026-02-02, before the market open.
INMD Technical Analysis
INMD Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to INMD. INMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
INMD Financial Highlights
Over the last trailing twelve months INMD reported a non-GAAP Earnings per Share(EPS) of 1.58. The EPS decreased by -23.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 41.1% | ||
| ROA | 20.39% | ||
| ROE | 22.93% | ||
| Debt/Equity | 0 |
INMD Forecast & Estimates
13 analysts have analysed INMD and the average price target is 17.14 USD. This implies a price increase of 22.14% is expected in the next year compared to the current price of 14.03.
For the next year, analysts expect an EPS growth of -9.5% and a revenue growth -8.12% for INMD